Search

Author/Creator Langholz, E

1. DOP019 Immunomodulators reduce the risk of surgery and hospitalisation in Crohn's disease in a prospective European population-based inception cohort: the Epi-IBD cohort. (16th January 2018)

Authors:
Burisch, J; Andersen, V; Čuković-Čavka, S; Lakatos, P L; D'Inca, R; Magro, F; Arebi, N; Kievit, L; Kaimakliotis, I; Valpiani, D; Katsanos, K H; Vegh, Z; Dahlerup, J F; Fumery, M; Pedersen, N; Halfvarson, J; Belousova, E; Nielsen, K R; Turcan, S; Ellul, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 1(2018:Jan.)Supplement 1
Page Start:
S042
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Issue 4 (20th April 2013)

Authors:
Burisch, J; Pedersen, N; Čuković-Čavka, S; Brinar, M; Kaimakliotis, I; Duricova, D; Shonová, O; Vind, I; Avnstrøm, S; Thorsgaard, N; Andersen, V; Krabbe, S; Dahlerup, J F; Salupere, R; Nielsen, K R; Olsen, J; Manninen, P; Collin, P; Tsianos, E V; Katsanos, K H
Journal:
Gut
Issue:
Volume 63:Issue 4(2014)
Page Start:
588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. OP15 Cost analysis in a prospective European population-based inception cohort: is there a cost-saving effect of biological therapy?. (25th January 2019)

Authors:
Burisch, J; Vardi, H; Schwartz, D; Krznaric, Z; Lakatos, P L; Fumery, M; Kupcinskas, L; Magro, F; Belousova, E; Oksanen, P; Arebi, N; Langholz, E; Turcan, S; D'Inca, R; Hernandez, V; Valpiani, D; Vegh, Z; Giannotta, M; Katsanos, K H; Duricova, D
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S009
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. OP18 Disease course of Crohn's disease during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort. (30th January 2023)

Authors:
Wewer, M D; Salupere, R; Kievit, H A L; Nielsen, K R; Midjord, J; Domislovic, V; Krznarić, Ž; Pedersen, N; Kjeldsen, J; Eriksson, C; Halfvarson, J; Talbot, A; Sebastian, S; Goldis, A; Misra, R; Arebi, N; Ilus, T; Oksanen, P; Neuman, A; Andersen, V
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i25
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P003 MicroRNAs as biomarkers in Inflammatory Bowel Disease unclassified (IBDU) patient samples may predict the development from IBDU to Crohn's Disease or Ulcerative Colitis. (30th January 2023)

Authors:
Pallikkunnath James, J; Riis, L B; Malham, M; Høgdall, E; Langholz, E; Nielsen, B S
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i171
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. P467 Therapeutic drug monitoring of biologics in Inflammatory Bowel Disease: Nordic survey on implementation and barriers in clinical practice. (21st January 2022)

Authors:
Bjørlykke, K; Jahnsen, J; Brynskov, J; Molander, P; Eberhardson, M; Davidsdottir, L G; Sipponen, T; Hjortswang, H; Langholz, E; Jørgensen, K K; Steenholdt, C
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗